218 related articles for article (PubMed ID: 36722129)
1. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
Huang Y; Xu L; Huang M; Jiang L; Xu M
Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.
Jiang L; Yan L; Wen T; Li B; Zeng Y; Yang J; Wang W; Xu M; Wu H
J Am Coll Surg; 2015 Nov; 221(5):951-61. PubMed ID: 26362135
[TBL] [Abstract][Full Text] [Related]
3. Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study.
Wan W; Zhang H; Ji T; Zhang L; Luo K; Xiong D
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102157. PubMed ID: 37321321
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
6. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
Wang C; Li K; Huang Z; Yuan Y; He W; Zheng Y; Zou R; Li B; Yuan Y; Qiu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15113-15125. PubMed ID: 37632543
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis.
Huang Y; Song J; Zheng J; Jiang L; Yan L; Yang J; Zeng Y; Wu H
Ann Surg Oncol; 2020 Jul; 27(7):2334-2345. PubMed ID: 32016632
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
9. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Resection Combined with Intraoperative Radiofrequency Ablation Versus Hepatic Resection Alone for Selected Patients with Moderately Advanced Multifocal Hepatocellular Carcinomas.
Zheng K; Liao A; Yan L; Yang J; Wen T; Wang W; Li B; Wu H; Jiang L
Ann Surg Oncol; 2022 Aug; 29(8):5189-5201. PubMed ID: 35441310
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.
Wei F; Huang Q; Zhou Y; Luo L; Zeng Y
World J Surg Oncol; 2021 Jun; 19(1):175. PubMed ID: 34127007
[TBL] [Abstract][Full Text] [Related]
12. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
[TBL] [Abstract][Full Text] [Related]
13. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
Yang D; Zhuang B; Wang Y; Xie X; Xie X
BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
[TBL] [Abstract][Full Text] [Related]
16. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
Hu L; Lin J; Wang A; Shi X; Qiao Y
World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
Zhou Q; Wang X; Li R; Wang C; Wang J; Xie X; Li Y; Li S; Mao X; Liang P
J Gastroenterol; 2022 Sep; 57(9):684-694. PubMed ID: 35816221
[TBL] [Abstract][Full Text] [Related]
18. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
[TBL] [Abstract][Full Text] [Related]
19. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
[TBL] [Abstract][Full Text] [Related]
20. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
